Concepedia

Eric D. Labonté

ED

Statistics

Publications

12

Citations

749

H-Index

12

Active since

2001

Affiliations

Ardelyx (United States)(Current)

University of Cincinnati

Canadian Institutes of Health Research

University of Alberta

University of Cincinnati Medical Center

Eric D. Labonté is an author at Ardelyx (United States) specializing in medicine, pharmacology, and physiology.

Top concepts

Publications per year

2001–2022

12

Publications

12

Intestinal Inhibition of the Na <sup>+</sup> /H <sup>+</sup> Exchanger 3 Prevents Cardiorenal Damage in Rats and Inhibits Na <sup>+</sup> Uptake in Humans

Andrew Spencer, Eric D. Labonté, David P. Rosenbaum et al. · Science Translational Medicine · 2014 · 146 citations

Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and<i>Npc1l1</i><sup>−/−</sup>mice

Eric D. Labonté, Lisa M. Camarota, Juan Camilo Rojas Echeverri et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2008 · 113 citations · Full text

Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD

Eric D. Labonté, Christopher W. Carreras, Michael R. Leadbetter et al. · Journal of the American Society of Nephrology · 2014 · 104 citations · Full text

, , +21

Group 1B Phospholipase A2–Mediated Lysophospholipid Absorption Directly Contributes to Postprandial Hyperglycemia

Eric D. Labonté, R. Jason Kirby, Nicholas M. Schildmeyer et al. · Diabetes · 2006 · 84 citations · Full text

Postprandial lysophospholipid suppresses hepatic fatty acid oxidation: the molecular link between group 1B phospholipase A <sub>2</sub> and diet‐induced obesity

Eric D. Labonté, Paul T. Pfluger, James G. Cash et al. · The FASEB Journal · 2010 · 75 citations

Rows per page

1–5 of 12